Tag:
ZD4054
Latest Headlines
Latest Headlines
AstraZeneca releases upbeat data on cancer drug
New data on AstraZeneca's promising prostate cancer therapy ZD4054 shows that patients taking the drug lived on average seven more months than patients receiving standard therapy. But the mid-stage
